好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A Case of Rapidly Progressive Juvenile-Onset Amyotrophic Lateral Sclerosis with a rare SOD1 genetic variant
Child Neurology and Developmental Neurology
P5 - Poster Session 5 (5:30 PM-6:30 PM)
7-067
NA

Juvenile-onset Amyotrophic Lateral Sclerosis (ALS) is a rare neurodegenerative disorder that affects the upper and lower motor neurons, slower than adult onset ALS and causes progressive muscle weakness, disability and eventually death.  5-10 % of cases are familial of which 15-30% are caused by pathologic variants in the Superoxide Dismutase-1 gene (SOD1).  Over 180 mutations of the SOD1 gene have been reported. 

NA
We present a 17-year-old female who presented with left calf pain followed by monomelic amyotrophy of the left lower extremity. Over the following nine-months, she progressed to quadriparesis with bulbar weakness and respiratory compromise, resulting in death. Nerve conduction studies and EMG demonstrated a chronic motor axonal polyneuropathy. Sensory abnormalities were noted in a repeat nerve conduction study during the progressive course. Nerve biopsy revealed axonal degeneration with patchy epineural and perivascular inflammation. Patient received immunomodulatory treatment including IVIG, steroids, plasmapheresis, rituximab and cyclophosphamide with continued neurologic decline. Whole Exome Sequencing showed a variant in the SOD1 gene, p.D125G. The father was found to be an asymptomatic carrier of this variant.

The p.D125G mutation represents a rare pathologic variant in the SOD1 gene presenting as juvenile onset ALS. This mutation, in prior studies, has been shown to be a non-conserved amino acid substitution that likely impacts  the conformation of the protein and resulting in abnormal aggregation. Functional studies in addition show this variant causing chronic stress to the endoplasmic reticulum by exposure to the Derlin-1 binding region. Reduced penetrance and interfamilial variability as well dorsal root ganglion degeneration, seen in prior reports of ALS are also exemplified in our case.

Authors/Disclosures
Alejandro J. De La Torre Ribadeneira, MD (Lurie Children's Hospital)
PRESENTER
No disclosure on file
Shailee S. Shah, MD Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Shah has received publishing royalties from a publication relating to health care.
Vamshi Rao, MD (Ann & Robert H Lurie Children's Hospital) No disclosure on file